Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Clinical Trial of Metformin in Those With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

NCT04530383 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT04530383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Clinical Trial of Metformin in Those With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Lead sponsor
University of Kansas Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
February 14, 2022
Completion date
July 15, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, cystic fibrosis-related diabetes